The prevention of fragility fractures in patients with non-metastatic prostate cancer: a position statement by the international osteoporosis foundation

Androgen deprivation therapy is commonly employed for the treatment of non-metastatic prostate cancer as primary or adjuvant treatment. The skeleton is greatly compromised in men with prostate cancer during androgen deprivation therapy because of the lack of androgens and estrogens, which are trophi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cianferotti, Luisella, Bertoldo, Francesco, Carini, Marco, Kanis, John A., Lapini, Alberto, Longo, Nicola, Martorana, Giuseppe, Mirone, Vincenzo, Reginster, Jean-Yves, Rizzoli, Rene, Brandi, Maria Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650454/
https://www.ncbi.nlm.nih.gov/pubmed/29088899
http://dx.doi.org/10.18632/oncotarget.17980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650454/
https://www.ncbi.nlm.nih.gov/pubmed/29088899
http://dx.doi.org/10.18632/oncotarget.17980

Ejemplares similares